Cyclerion Therapeutics (CYCN) Payables (2019 - 2025)
Historic Payables for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $480000.0.
- Cyclerion Therapeutics' Payables rose 5789.47% to $480000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $480000.0, marking a year-over-year increase of 5789.47%. This contributed to the annual value of $390000.0 for FY2024, which is 6744.57% down from last year.
- As of Q3 2025, Cyclerion Therapeutics' Payables stood at $480000.0, which was up 5789.47% from $462000.0 recorded in Q2 2025.
- Cyclerion Therapeutics' 5-year Payables high stood at $4.9 million for Q2 2021, and its period low was $304000.0 during Q3 2024.
- Moreover, its 5-year median value for Payables was $1.6 million (2022), whereas its average is $2.0 million.
- In the last 5 years, Cyclerion Therapeutics' Payables skyrocketed by 21469.58% in 2021 and then crashed by 8112.1% in 2024.
- Cyclerion Therapeutics' Payables (Quarter) stood at $1.8 million in 2021, then skyrocketed by 62.47% to $3.0 million in 2022, then crashed by 59.66% to $1.2 million in 2023, then tumbled by 67.45% to $390000.0 in 2024, then increased by 23.08% to $480000.0 in 2025.
- Its last three reported values are $480000.0 in Q3 2025, $462000.0 for Q2 2025, and $483000.0 during Q1 2025.